FDA curbs use of antibody drugs sidelined by omicron
WASHINGTON (AP) - COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the omicron variant that now accounts for…
WASHINGTON (AP) - COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the omicron variant that now accounts for…